BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.29
+0.24 (1.41%)
At close: May 29, 2026, 4:00 PM EDT
17.68
+0.39 (2.26%)
After-hours: May 29, 2026, 7:16 PM EDT
BioAge Labs Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, BioAge Labs stock has a consensus rating of "Buy" and an average price target of $49.5. The average 1-year stock price forecast is 186.29% higher than the current stock price, while the lowest is $23 (+33.02%) and the highest is $73 (+322.21%).
Price Target: $49.5 (+186.29%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioAge Labs stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 3 | 3 | 3 | 5 |
| Buy | 0 | 1 | 1 | 2 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 7 | 7 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Initiates $36 | Buy | Initiates | $36 | +108.21% | May 27, 2026 |
| BTIG | BTIG | Buy Initiates $40 | Buy | Initiates | $40 | +131.35% | May 13, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 11, 2026 |
| Needham | Needham | Buy Maintains $50 | Buy | Maintains | $50 | +189.18% | May 11, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $23 | Hold | Maintains | $23 | +33.02% | May 8, 2026 |
Financial Forecast
Revenue This Year
59.25M
from 9.00M
Increased by 558.65%
Revenue Next Year
3.54M
from 59.25M
Decreased by -94.02%
EPS This Year
-2.66
from -2.24
EPS Next Year
-2.62
from -2.66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 498.8M | 11.0M | ||||||
| Avg | 59.2M | 3.5M | ||||||
| Low | n/a | -2.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5,444.7% | -81.4% | ||||||
| Avg | 558.7% | -94.0% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.39 | -1.74 | ||||||
| Avg | -2.66 | -2.62 | ||||||
| Low | -3.07 | -3.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.